ATP-sensitive inwardly rectifying potassium channels are expressed in a variety of tissues, including heart, skeletal, and smooth muscle, and pancreatic fi-cells. Physiological and pharmacological studies suggest the presence of distinct K ATP channels in these tissues. Recently, the K ATP channel of p-cells has been reconstituted in functional form by coexpression of SUR, the sulfonylurea-binding protein, and the inwardly rectifying K + channel subunit, KIR6.2. In this article, we describe the isolation of cDNAs encoding SUR-like proteins from mouse, SUR2A and SUR2B. Northern blotting showed that the highest expression of the SUR2 isoforms is in the heart and skeletal muscle, with lower levels in all other tissues. By reverse transcription-polymerase chain reaction, SUR2B is ubiquitously expressed, while the apparently alternatively spliced variant, SUR2A, is expressed exclusively in heart. In situ hybridization shows that the SUR2 isoforms are expressed in the parenchyma of the heart and skeletal muscle and in the vascular structures of other tissues. Human SUR2 was localized to chromosome 12, pi2.1 by fluorescent in situ hybridization. The structure of the predicted protein and expression pattern of SUR2 suggests that it is the drug-binding channel-modulating subunit of the extrapancreatic K ATP channel. Differences in sequence between SUR and between SUR2 isoforms may underlie the tissuespecific pharmacology of the K ATP channel.
coupling energy stores to other cellular processes (4) (5) (6) (7) . Modulation in the levels or activity of K ATP channels have been implicated in ischemic preconditioning (5) , vasodilatation (6) , and insulin release (2, 7) .
K ATP channels can be regulated by a number of important pharmacological agents (2, 4) , such as glybenclamide (glyburide), a potent inhibitor of fJ-cell K ATP channels. The Kj for glybenclamide inhibition of whole p-cell potassium currents is -5-10 nmol/1; however, it is -50-fold less potent in inhibiting the heart and smooth muscle K ATP channel (8) , emphasizing differences between the (3-cell and extrapancreatic K ATP channels. K ATP channel openers include diazoxide, nicorandil, minoxidil, pinacidil, and cromakalim. These agents cause vasodilatation and shorten the action potential in the heart and may act to decrease the ATP sensitivity of the channel (9,10) but likely bind to a site distinct from the sulfonylureas (11) . Again, there appear to be differences in the sensitivity of cardiac, vascular smooth muscle, and (3-cell K ATP channels to the different activators (4, 12) . Extrapancreatic sulfonylurea-regulated potassium channels have gained renewed interest because of their possible relationship to increased cardiovascular risk in NIDDM subjects treated with oral hypoglycemic agents (13) .
Recently, the pancreatic sulfonylurea-binding protein, SUR, was identified (14) . Functional reconstitution of a K ATP channel was achieved once SUR was coexpressed with the inwardly rectifying potassium channel KIR6.2 (15, 16) . SUR is a member of the ATP-binding cassette (ABC) family of proteins and appears to function by modulating the activity of the potassium pore protein (17) . In this article, we describe the isolation and tissue expression pattern of novel SUR-like cDNAs, SUR2A and SUR2B, which likely form the drug-binding subunit of extrapancreatic K ATP channels.
RESEARCH DESIGN AND METHODS
Library screening. The following libraries were screened using ;l "P-labeled DNA probes (10° dpm/ml) under standard high-stringency conditions (18) : rat skeletal muscle cDNA ZAP (Stratagene), mouse cardiac cDNA ZAPI1 (Stratagene), human skeletal muscle cDNA (Clonetech), and human liver genomic (Clonetech). Clonal plaques were amplified on single plates at a high titer (-5,000 plaques/plate), and the phage DNA was purified by Wizard lambda DNA preparations (Promega). Except for the mouse cDNA, the cDNA inserts were excised and subcloned into pGEM 7Z (Promega) for sequencing. Clonal plaques from the mouse cDNA library were amplified on single plates under a high titer (~5,000 plaques/plate), and the cDNA inserts were excised in vivo after coincubation with the ExAssist helper phage fol-lowing the manufacturer's protocol. The excised cDNA inserts were sequenced by dye termination cycle sequencing (ABI Pyramid Automated Sequencer, Perkin Elmer). 5' RACE and full-length mouse cDNA clone construction. The 5' end of the mouse clone was determined by a commercial RACE kit (Clonetech) following the manufacturer's suggestion. RACE products were gel purified and subcloned into pGEM 7z (Promega) for sequence analysis. Four independent RACE reactions were performed with identical results. To construct a full-length mouse cDNA, a Pfu polymerase (Stratagene) amplified RACE fragment and the largest cDNA library clone (designated mSUR2 7.7) were amplified in methylation-deficient DM1 cells (Gibco BRL) to reveal a common Clal site residing within a dam methylation consensus site. The two subfragments were directionally ligated into pCDNA3 (Invitrogen). Sequence prediction of the encoded protein was performed using the Prosite program, accessed through ExPASy on the World Wide Web. Reverse transcription-polymerase chain reaction (RT-PCR) analysis of spliced variant. Primers for reverse transcription-polymerase chain reaction (RT-PCR) amplification were defined to a highly divergent coding region between SUR and SUR2. The primer sequences were as follows: primer A 5'-TGCGACATTTGTGACACATG-3' at 1,870 bp and primer B 5'-CGTAAGCCACAGAATACCTGC-3' at 2,369 bp. cDNA templates were generated from total RNA primed with primer B and reversed transcribed with Superscript II (Gibco BRL) following manufacturer's instructions. The cDNA templates were PCR-amplified with Taq polymerase (Gibco BRL) under the following conditions: 35 cycles of 94°C x 45 s, 57°C x 45 s, and 72°C x 45 s, and the products were electrophoresed on 2% agarose gels and visualized by ultraviolet (UV) fluorescence. The PCR products from heart and kidney were blunted and kinased (18) and subcloned into Smal-digested pGEM 7z for sequencing, as described above.
RNA preparation and Northern blotting. Mouse tissues were harvested from female CD4 mice, RNA extracted by TRIzol reagent (Gibco BRL), and 20 ug of total RNA electrophoresed on 1% agarose/formaldehyde gels. After transfer to positive-charged nylon membranes (Amersham) and UV crosslinkage, they were probed with species-specific 32 P-labeled cDNA probes generated by random priming (Amersham) and hybridized at 42°C (10 6 dpm/ml) in 50% formamide. Blots were washed under standard high-stringency conditions (18) with the final wash of 0.1 x sodium chloride-sodium citrate (SSC), 0.1% sodium dodecyl sulfate at 65°C. Commercial poly A + RNA blots of rat and human tissues (Clonetech) were probed under similar conditions. In situ hybridization. As previously described (19) , whole fixed mouse embryos were embedded in paraffin and sectioned. Sense and antisense RNA probes corresponding to nucleotides 565-1006 in the 5' coding region of SUR2 were in vitro transcribed in the presence of 35 S uridine triphosphate (UTP) (800 mCi/mmol, Amersham) using T7 and SP6 RNA polymerases (Promega). Tissue-mounted slides were hybridized at 6 X 10 G cpm/slide for 16 h at 60°C. The slides were washed under high-stringency conditions (50% formamide/2x SSC/20 mmol/1 dithiothreitol at 63°C) followed by digestion with 20 ug/ml RNase A at 37°C. The hybridized tissues were then coated with emulsion (Kodak NTB-2) and autoradiographed at 4°C for 7 days. Developed slides were counterstained with Hoechst stain and viewed by epifluorescence. Fluorescent chromosomal in situ hybridization. Human metaphase cells were prepared from phytohemagglutinin-stimulated peripheral blood lymphocytes (20) . The hSUR2 3.1.2 clone was a 15-kb genomic DNA insert isolated from a human liver genomic library (Clonetech). Fluorescence in situ hybridization was performed, as described previously (20) . Biotin-labeled probes were prepared by nick-translation using Bio-11-dUTP (Enzo Diagnostics). Hybridization was detected with fluorescein-conjugated avidin (Vector Laboratories), and chromosomes were identified by staining with 4,6-diamindino-2-phenylindole-dihydrochloride. Images were obtained using a Zeiss Axiophot microscope coupled to a cooled charge coupled device camera. Separate images of 4',6-diamidino-2-phenylindole dihydrochloride (DAPI)-stained chromosomes and the hybridization signal were merged using image analysis software (NU200 and Image 1.52b).
RESULTS
During the amplification of a differentially expressed gene from rat skeletal muscle using the technique of differential display PCR (21), we recovered a 389-bp nucleotide fragment, which showed 86% sequence homology to the recently cloned rat sulfonylurea receptor, SUR (14) . This fragment was used to screen and obtain partial rat, mouse, and human cDNA clones. The longest mouse clone was 5,980 nucleotides in length. RACE amplification of mouse heart cDNA was used to isolate the 5' end of the mouse clone, which included the initiating methionine, and consistently gave two products differing by 21 base pairs in the 5' untranslated region. The mouse cDNA clone contained an open reading frame of 4,535 nucleotides beginning with the second ATG. An apparent alternatively spliced form of this cDNA (see below) contained a 105-bp insert in the coding region beginning at amino acid 654 (Fig. L4, highlighted) . The predicted proteins contain 1,512 and 1,547 amino acids with a molecular weight of 170,111 and 174,260 daltons and exhibit 67 and 68% homology to the rat SUR protein (Fig. L4) . The predicted proteins are members of the ABC transport family (22) based on their possession of two nucleotidebinding folds, and they share similar structural features and predicted topology with SUR ( Fig. L4 and E) . Given the homology, this cDNA is designated SUR2, with the smaller and larger forms designated as SUR2A and SUR2B, respectively.
Northern blotting of total RNA from mouse tissues showed the presence of two transcripts of 9.4 and 8.6 kb ( Fig. 2A) . The 8.6-kb transcript was ubiquitously expressed, while the 9.4-kb transcript was observed primarily in skeletal muscle and heart, with lower levels in aorta and bladder. Probing RNA from human tissues showed three transcripts of -9.4, 7.6, and 5.6 kb (Fig. 2E) , with the highest level of the larger transcript expressed in heart and skeletal muscle. RNA from rat tissues exhibited expression of SUR2 in skeletal muscle, heart, and fat, with only a single transcript of 7.6 kb detected (Fig. 2(7) .
Given the multiple transcripts expressed in mouse tissues, the possibility of coding region variation was investigated using RT-PCR. Using PCR primers that would not be predicted to amplify SUR (nucleotides 1870-1890 [forward] and 2348-2369 [reverse]), two products of -500 and -600 bp were obtained from heart, while only the -600 bp product was amplified from other tissues (Fig.  2JD) . Sequencing of these PCR products showed that an additional 105 bp are present in the presumed spliced variant of SUR2 (Fig. L4, highlighted sequence) . No other coding region differences were observed (data not shown). These results suggest that additional differences exist in the 3' end of the cDNA to give rise to the multiple bands seen on Northern blotting.
In situ hybridization performed on day-16.5 mouse embryos showed heavy expression in virtually every tissue (Fig. 3) . Homogeneous staining in the parenchyma of the ventricle (Fig. 3^4 and B, inset) and skeletal muscle structures (for example, tongue; Fig. 3A and E) was evident at low magnification, while other tissues exhibited a heterogeneous or mottled staining. Higher magnification revealed specific hybridization in the medial layer of the aorta, in vascular structures of the thymus (Fig. 3C and  D) , outlining the alveoli of the lung (Fig. SE and F) , in the muscularis layer of the small and large intestine ( Fig. 3G  and H) , and in the vascular structures of the brain and smooth muscle layer of the paranasal sinuses (Fig. 3/ and  J) . In addition, specific staining was also seen in most other tissues in areas corresponding to vascular structures. Significantly, there was almost an absence of specific staining in the vasculature of the liver. 
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•' . ;X X S : -f. y r I ' ; ". Fluorescence in situ hybridization of a biotin-labeled probe resulted in specific labeling only of chromosome genomic human SUR2 probe was performed on normal 12 (Fig. 4) . Specific labeling of 12pll.l2 was observed on human metaphase chromosomes. Hybridization of this four (two cells), three (four cells), two (ten cells), or one (nine cells) chromatid(s) of the chromosome 12 homologues in 25 cells examined. Of 49 signals observed on 12p, 1 (2%) signal was located at 12pll, 42 (86%) signals were located at 12pl2.1, and 6 (12%) signals were located at 12pl2.3. Seventeen single background signals were observed at seventeen other random chromosomal sites. We observed a specific signal at 12pl2.1 in a second hybridization experiment using this probe (25 cells examined); 61 of 65 signals observed were located at 12pl2. These results suggest that human SUR2 is localized to chromosome 12 at band pl2.1.
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DISCUSSION
The minimum (3-cell K ATP channel is a heterodimer of a SUR protein, the apparent drug-binding regulatory subunit, and a smaller protein that functions as the potassium pore (8, 16, 17) , and SUR2B shows that the greatest sequence divergence resides in a domain, predicted to be intracellular, toward the NH 2 -terminal from the first ATP-Binding Walker motif (Fig. IB) . Part of this domain contains the 35 amino acid peptide unique to SUR2B. RT-PCR analysis demonstrates that the 105-bp insert encoding the SUR2B insert is present in each tissue examined (Fig. 2D) and likely correlates both with the ubiquitously expressed 8.6-kb band witnessed by Northern blotting (Fig. 2A) and with expression in vascular structures, as evidenced by in situ hybridization (Fig.  3) . The mouse SUR2A variant has been found only in heart and may be the parenchymal form identified by in situ hybridization (Fig. 3A) , while the SUR2B variant also identified in mouse cardiac tissue could be associated with the vasculature of the heart. SUR2A and SUR2B may arise from alternative splicing of the SUR2 mRNA, since the 105-bp insert is bounded by donor/acceptor sequences and corresponds exactly to exon 14 of the human SUR gene (24) . The 35-amino acid sequence encoded by this insert has little homology to sequences in SUR. Given its position in SUR2, close to the ATP-binding motif, and the observation that this is the domain that is the most divergent between SUR and SUR2A and SUR2B, we speculate that this domain may modulate drug-binding or ATP sensitivity, thereby giving rise to the known differences in the pharmacological properties of the pancreatic, vascular, and cardiac K ATP channels. SUR and KIR6.2 form the functional K ATP channel of the pancreatic (3-cell and these two K ATP subunits map to the same locale on human chromosome 11 (16) . Human KIR 6.1, recently described by Inagaki et al. (25) , is located on chromosome 12, position pi 1.23. We have found that human SUR2 is also located on chromosome 12 and maps to the same site as KIR6.1, suggesting a common ancestor for the K ATP subunits. These results also would suggest that SUR2 may couple to KIR6.1. In the preparation of this article, it has come to our attention that Inagaki et al. (26) have also cloned the rat isoform of SUR2 from a rat brain library. Their clone contains the larger putative spliced variant of SUR2 and is likely the vascular form that we observe in the brain by in situ hybridization (Fig. 3) . This larger form coupled functionally when coexpressed with KIR6.2. Whether the spliced variant forms of SUR2 couple to different potassium pore proteins remains to be determined.
In the pancreatic fS-cells, K ATP channels appear to "sense" an increased energy charge of the cell by closing in response to an increase in ATP/ADP ratio, resulting in insulin release from the fJ-cell. The central role of the pancreatic K ATP channel is underscored in persistent hyperinsulinemic hypoglycemia of infancy (PHHI) in which mutations of the SUR subunit of the channel lead to unregulated insulin secretion. The exact role of the extrapancreatic K ATP channel under normal physiological conditions is not known. It is tempting to speculate that it also functions to "sense" energy levels and modulate the ability of tissue to expend or accumulate energy stores. Indeed, in skeletal muscle and heart, channel activity is increased with ischemia, resulting in decreased calcium influx and contractile force, thus 
